Airway diseases
Interstitial lung diseases
Oral presentation
Optimising outcomes of lung transplantation: how to move forward?
Aims : This session is built from abstracts published on the ERS Congress platform from 23 August, in a PowerPoint format with a pre-recorded audio narration. The live session is scheduled from September 5-7 and each presenter will have a 5-minutes live, slide show presentation followed at the end of the session by 30-minutes general discussion.
This session includes the Best Abstract for Assembly 8 - Thoracic Surgery and Transplantation, entitled "Host response towards decellularised lung extracellular matrix reinforced bioinks for 3D bioprinting lung tissue for transplantation”
Methods :
Pulmonary rehabilitation, Transplantation, General respiratory patient care, Surgery, Respiratory intensive care
09:30
Introduction
1
OA2908
09:35
Interstitial lung diseases and transplantation - how to choose the best candidate?
M. Šterclová(Praha, Czech Republic)
COI
2
09:40
The impact of colonization with therapy-resistant pathogens on the survival rate after lung transplantation (LUTX) in cystic fibrosis (CF)
B. Weingard(Homburg (Saar), Germany)
COI
3
09:45
Does assessing frailty in lung transplant candidates on the waiting list provide information?
A. Gómez Garrido(Barcelona, Spain)
COI
4
09:50
Reduced ventilatory efficiency during exercise in lung transplant recipients
F. Braccioni(Padova, Italy)
COI
5
09:55
Basiliximab vs antithymocyte globulin after lung transplantation: A national review
B. de Aguiar Mendes(Lisboa, Portugal)
COI
6
10:00
Electronic nose for detecting chronic lung allograft dysfunction in lung transplant recipients
N. Wijbenga(Rotterdam, Netherlands)
COI
7
10:05
Oxygenated hemoglobin predicts outcome in patients with chronic lung allograft dysfunction
K. Kahnert(München, Germany)
COI
8
10:10
Comparison of extracorporeal photopheresis efficacy in treated versus non-treated patients with refractory BOS.
B. Renaud-Picard(Strasbourg, France)
COI
9
10:20
Late Breaking Abstract - Good outcome for lung transplantation for adults with interstitial lung disease associated with genetic disorders of surfactant metabolism
J. Bermudez(Marseille, France)
COI
10
10:25
Discussion
11
OA2919
. . .
